Open partial nephrectomy for the treatment of renal cell carcinoma.
Open partial nephrectomy, or nephron-sparing surgery (NSS), is now considered the standard of care for the treatment of small renal tumors. The oncologic efficacy and safety of NSS for the treatment of stage-T1a renal tumors has been repeatedly demonstrated to be equivalent to radical nephrectomy. NSS initially was reserved for patients with solitary kidneys, impaired renal function, hereditary tumor syndromes, bilateral renal tumors, and those with significant comorbidities predisposing to future renal failure. The indications have expanded recently to allow elective partial nephrectomy in the setting of a normal contralateral kidney. Furthermore, recent data demonstrate that partial nephrectomy for larger tumors (T1b), which have been historically treated with radical nephrectomy, is a viable option when surgical margins can safely be achieved. In the era of minimally invasive techniques, laparoscopic NSS is technically feasible, yet long-term studies are still needed to assess oncologic efficacy. New NSS ablative technologies, such as cryoablation and radiofrequency ablation, are on the horizon. In this article, we discuss the role of open NSS and surgical technique in the contemporary management of renal tumors.
Department of Urology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095-1738, USA.
Brian
B
Shuch
John S
JS
Lam
Arie S
AS
Belldegrun
D001706:Biopsy; D002292:Carcinoma, Renal Cell / Q000601:surgery*; D004564:Electrocoagulation; D005629:Frozen Sections; D006801:Humans; D007036:Hypothermia, Induced; D007680:Kidney Neoplasms / Q000601:surgery*; D009392:Nephrectomy / Q000379:methods*; D018084:Ultrasonography, Interventional